Word

BIOMARK

Status

Pending

Status Code

661

Status Date

Friday, April 12, 2024

Serial Number

97873713

Mark Type

4

Filing Date

Wednesday, April 5, 2023

Trademark Owner History

BIOMARK CANCER SYSTEMS INC.

Classifications

5 Antibody reagents for in vitro diagnostic use for medical purposes; diagnostic kits consisting of monoclonal antibodies, buffers, and reagents for in vitro diagnostic use for medical purposes; medical diagnostic antibody reagents for use in medical imaging; diagnostic kits consisting of monoclonal antibodies, buffers and reagents for specialized medical Raman spectrometry to monitor toxicity of drugs for medical purposes, for use in disease testing, for testing of bodily fluids for use in disease detection, namely, cancer, for screening the acetylated form of Amantadine in body fluids and human tissues samples, for use in the early detection of cancer by detecting and analyzing the levels of Spermine/Spermidine N-Acetyl Transferase (SSAT) in human tissue samples; medical diagnostic assays for testing bodily fluids in drug screening applications, namely, assays for determining the efficacy of anti-cancer drugs; medical diagnostic assays for testing bodily fluids that test for the presence and effects of drug candidates in the body; drug testing kits comprised of medial diagnostic reagents and assays for testing body fluids; medical diagnostic reagents and assays for the analysis of body fluids; diagnostic biomarker reagents for medical purposes

44 Medical testing of a biological sample taken from a patient for diagnostic purposes in the field of oncology; medical testing of a biological sample taken from a patient for medical screening purposes in the field of oncology; providing medical evaluation to assess and measure response to cancer treatment; medical analysis services relating to the treatment of cancer patients to help healthcare professionals determine the effectiveness of treatments and to revise future treatments; medical diagnostic testing, monitoring and reporting services relating to disease recurrence and progression in the field of oncology; providing medical support in the monitoring of patients receiving medical treatments, namely remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes, interactive medical monitoring and alert service for reminding clients of medical dosage, allergic sensitivity and prescription refills for medical treatment purposes; providing medical information to medial professionals in the form of analytical reports and risk classification or stratification in the field of oncology; providing medical information to patients and medical professionals in the form of reports in the field of oncology

42 Providing an interactive web site featuring technology that enables users to enter, access, track, store, monitor, analyze and generate health and medical information and reports

Trademark Events

Apr 8, 2023

New Application Entered

May 1, 2023

New Application Office Supplied Data Entered

Jan 2, 2024

Assigned To Examiner

Apr 12, 2024

Correspondence Received In Law Office

Apr 12, 2024

Teas/Email Correspondence Entered

Apr 12, 2024

Teas Response To Office Action Received

Jan 12, 2024

Notification Of Non-Final Action E-Mailed

Jan 12, 2024

Non-Final Action Written

Jan 12, 2024

Non-Final Action E-Mailed